Moreover, increased EZH2 expression could significantly promote tumor cell migration and invasion, and is strongly associated with tumor metastasis and poor clinical prognosis in a variety of human tumors such as breast, prostate, endometrial, gastric, colon, hepatocellular, bladder and oral cancers [11-18]. Here, EZH2 is linked to lip and oral cavity carcinoma.